{
    "clinical_study": {
        "@rank": "15077", 
        "biospec_descr": {
            "textblock": "5 ml of blood will be collected, 2ml of serum will be isolated from the blood and stored\n      below -80C till completion of the study."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "In the proposed project the investigators will asses whether changes in expression of\n      selected circulating microRNAs in serum could comprise a sensitive and specific biomarker of\n      cardiotoxicity in cancer patients treated with anthracyclines based chemotherapy."
        }, 
        "brief_title": "Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Blood will be taken\n\n        1. before anthracycline based chemotherapy administration\n\n        2. at the middle of anthracycline treatment (before 3rd and/or 5th cycle of drugs\n           infusion)\n\n        3. after anthracycline chemotherapy cessation\n\n        4. 6 months after chemotherapy cessation if an end point occurs\n\n        5. 12 months after chemotherapy cessation if an end point occurs\n\n      Echocardiography will be performed\n\n        1. before anthracycline based chemotherapy administration\n\n        2. after anthracycline based chemotherapy cessation\n\n        3. 6 months after anthracycline based chemotherapy cessation\n\n        4. 12 months after anthracycline based chemotherapy cessation if no end point was observed\n           earlier The investigators will perform high-throughput miRNA(microRNA) expression\n           profiling of serum samples - called training set.\n\n      Training set will consist of sera of 30 patients who has reached an end point. Training set\n      will be sequenced using next generation sequencing.\n\n      Training set will be used to derive a miRNA signature capable of separating early\n      cardiotoxicity patients from healthy ones. MiRNA signature will be validated using\n      validation set."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 18-70\n\n          -  stage I-III TNM (Tumor Node Metastases)\n\n        Exclusion Criteria:\n\n          -  second or next cancer (except for basal cell skin cancer and CIN)\n\n          -  previously treated with chemotherapy\n\n          -  previously treated with radiotherapy\n\n          -  acute myocardial infarction\n\n          -  heart failure\n\n          -  cardiomyopathy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women with newly diagnosed breast cancer that will be treated with anthracyclines will be\n        recruited."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065908", 
            "org_study_id": "ZCO-2014-BD"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "breast cancer", 
            "anthracyclines", 
            "cardiotoxicity", 
            "circulating microRNA", 
            "biomarker", 
            "serum", 
            "anthracyclines based chemotherapy"
        ], 
        "lastchanged_date": "March 22, 2014", 
        "location": [
            {
                "contact": {
                    "email": "bdabek@onkologia.szczecin.pl", 
                    "last_name": "Bartosz D\u0105bek, MD", 
                    "phone": "+4891 4251500"
                }, 
                "facility": {
                    "address": {
                        "city": "Szczecin", 
                        "country": "Poland", 
                        "state": "West Pomeranian", 
                        "zip": "71-730"
                    }, 
                    "name": "Clinical Oncology Department, West Pomeranian Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Bartosz D\u0105bek, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "stachowiak22@gmail.com", 
                    "last_name": "Pawe\u0142 Stachowiak, MD", 
                    "phone": "+48914661378"
                }, 
                "facility": {
                    "address": {
                        "city": "Szczecin", 
                        "country": "Poland", 
                        "zip": "70-111"
                    }, 
                    "name": "Pomeranian Medical University, Department of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Pawe\u0142 Stachowiak, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_groups": "1", 
        "official_title": "Circulating microRNAs as a Novel Biomarker of Early Cardiotoxicity in Breast Cancer Patients Treated With Anthracyclines", 
        "overall_contact": {
            "email": "bdabek@onkologia.szczecin.pl", 
            "last_name": "Bartosz D\u0105bek, MD"
        }, 
        "overall_contact_backup": {
            "email": "stachowiak22@gmail.com", 
            "last_name": "Pawe\u0142 Stachowiak, MD"
        }, 
        "overall_official": {
            "affiliation": "West Pomeranian Cancer Center", 
            "last_name": "Bartosz D\u0105bek, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "either a cardiomyopathy with decreased left ventricular ejection fraction (LVEF), a reduction of LVEF \u22655% to <55% with symptoms of heart failure (e.g. orthopnoea and paroxysmal nocturnal dyspnoea, elevated jugular venous pressure, S3 gallop, Hepatojugular reflux, tachycardia), or an asymptomatic reduction of LVEF \u226510% to <55%", 
            "measure": "Cardiotoxicity events according to CREC (Cardiac Review and evaluation Committee) criteria", 
            "safety_issue": "Yes", 
            "time_frame": "up to 76 weeks after chemotherapy conclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065908"
        }, 
        "responsible_party": {
            "investigator_affiliation": "West Pomeranian Cancer Center", 
            "investigator_full_name": "Bartosz D\u0105bek", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "West Pomeranian Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Pomeranian Medical University Szczecin", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "West Pomeranian Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}